Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2008-2-18
pubmed:abstractText
The host response to intravascular, Gram-negative bacteria includes profound immunologic, hematologic and physiologic changes. Numerous host defense mechanisms are activated by Gram-negative bacteria, including the complement system. Activation of the complement system leads to cleavage of C5 with subsequent generation of the C5a anaphylatoxin peptide. C5a mediates potent, proinflammatory activities by binding to the C5a receptor (C5aR, CD88). In this study, we report the targeted disruption of the murine C5aR gene (C5aR-/- mice) and define the role of the C5aR in a model of Gram-negative bacteremia. Following an intravenous infusion of heat-killed Escherichia coli, the C5aR-/- mice were completely protected from the mortality suffered by their wild-type littermates (P<0.001). The C5aR-/- mice were also significantly (P=0.008) more resistant to mortality following an intravenous infusion of purified E. coli endotoxin compared to the wild-type littermates. In addition, the C5aR-/- mice were resistant to the thrombocytopenia and hemoconcentration observed in wild-type animals. Lethality in the wild-type mice was reversed by pre-treatment with either the histamine antagonist diphenhydramine or triprolidine. The wild-type littermates were also rescued following pre-treatment with the basophil and mast cell-stabilizing agent - cromolyn sodium. Collectively, these data demonstrate that not only is the absence of the C5aR protective in E. coli bacteremia, but that C5aR-dependent histamine release plays a major role in shock induced by Gram-negative septicemia. Moreover, they provide additional in vivo evidence that C3a and C5a have divergent biological functions in Gram-negative bacteremia and shock.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/K08 DK062197, http://linkedlifedata.com/resource/pubmed/grant/R01 AI025011, http://linkedlifedata.com/resource/pubmed/grant/R01 AI025011-11, http://linkedlifedata.com/resource/pubmed/grant/R01 AI025011-12, http://linkedlifedata.com/resource/pubmed/grant/R01 AI025011-13, http://linkedlifedata.com/resource/pubmed/grant/R01 AI025011-14, http://linkedlifedata.com/resource/pubmed/grant/R01 AI025011-15, http://linkedlifedata.com/resource/pubmed/grant/R01 AI025011-16, http://linkedlifedata.com/resource/pubmed/grant/R01 DK071057, http://linkedlifedata.com/resource/pubmed/grant/R01 HL074333, http://linkedlifedata.com/resource/pubmed/grant/R01 HL074333-01, http://linkedlifedata.com/resource/pubmed/grant/R01 HL074333-02, http://linkedlifedata.com/resource/pubmed/grant/R01 HL074333-03, http://linkedlifedata.com/resource/pubmed/grant/R01 HL074333-04
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0161-5890
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1907-15
pubmed:dateRevised
2011-9-22
pubmed:meshHeading
pubmed-meshheading:18063050-Acute Disease, pubmed-meshheading:18063050-Animals, pubmed-meshheading:18063050-Bacteremia, pubmed-meshheading:18063050-Complement C3a, pubmed-meshheading:18063050-Complement C5a, pubmed-meshheading:18063050-Disease Susceptibility, pubmed-meshheading:18063050-Flow Cytometry, pubmed-meshheading:18063050-Gene Targeting, pubmed-meshheading:18063050-Gram-Negative Bacteria, pubmed-meshheading:18063050-Hematocrit, pubmed-meshheading:18063050-Histamine Antagonists, pubmed-meshheading:18063050-Immunity, Innate, pubmed-meshheading:18063050-Macrophages, Peritoneal, pubmed-meshheading:18063050-Mast Cells, pubmed-meshheading:18063050-Mice, pubmed-meshheading:18063050-Platelet Count, pubmed-meshheading:18063050-Receptor, Anaphylatoxin C5a, pubmed-meshheading:18063050-Shock, Septic
pubmed:year
2008
pubmed:articleTitle
Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a.
pubmed:affiliation
Research Center for Immunology and Autoimmune Diseases, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas-Houston, TX77030, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural